Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 5.10.2015 | EN | Official Journal of the European Union | C 328/9 |

---

Order of the General Court of 16 July 2015 — Opko Ireland Global Holdings v OHIM — Teva Pharmaceutical Industries (ALPHAREN)

(Case T-106/15)[(1)](#ntr1-C_2015328EN.01000901-E0001)

((Community trade mark - Opposition proceedings - Revocation of the contested decision by OHIM - No need to adjudicate))

(2015/C 328/07)

Language of the case: English

Parties

Applicant: Opko Ireland Global Holdings (Dublin, Ireland) (represented by: S. Malynicz, Barrister, and A. Smith, Solicitor)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: A. Folliard-Monguiral, acting as Agent)

Other party to the proceedings before the Board of Appeal of OHIM intervening before the General Court: Teva Pharmaceutical Industries Ltd (Jerusalem, Israel) (represented by: G Farrington, Solicitor)

Re:

Action brought against the decision of the Fifth Board of Appeal of OHIM of 26 November 2014 (Case R 2387/2014-5) relating to opposition proceedings between Teva Pharmaceutical Industries Ltd and Opko Ireland Global Holdings Ltd.

Operative part of the order

|  |  |
| --- | --- |
| 1. | There is no need to adjudicate on the action. |

|  |  |
| --- | --- |
| 2. | The Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) shall bear all of the costs. |

---

[Top](#document1)